跳至主要内容
临床试验/ISRCTN01258591
ISRCTN01258591已完成不适用

Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery

niversity of Heidelberg (Germany)0 个研究点目标入组 68 人开始时间: 2006年4月27日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 up to and including 60 years
  • 2. Clinical signs of an ischemic infarction of the middle cerebral artery with a score on the National Institutes of Health Stroke Scale (NIHSS) >18 for lesions of the non-dominant hemisphere and >20 for lesions of the dominant hemisphere
  • 3. Neuroradiological signs of an unilateral infarction of the middle cerebral artery including at least two-thirds or more of the territory of the middle cerebral artery and including at least partly the basal ganglia, with or without an additional infarction of the anterior or posterior cerebral artery on the same side
  • 4. Onset of symptoms before more than 12 and less than 36 hours prior to a possible surgical intervention
  • 5. Possibility to start treatment or surgery within 6 hours after randomisation

排除标准

  • 1. Pre-stroke score on the modified Rankin Scale >2 or on the Barthel Index <95 (Rankin et al. 1957, Mahoney et al. 1965)
  • 2. Glasgow Coma Scale <6 at the time of randomisation
  • 3. Coincidental other brain lesion (i.e. trauma)
  • 4. Two fixed dilated pupils
  • 5. Secondary bleeding in the area of infarction
  • 6. Known systemic bleeding disorder
  • 7. Life expectancy <3 years
  • 8. Other serious illness that may confound treatment assessment

研究者

发起方
niversity of Heidelberg (Germany)

相似试验